echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Cardiovasc Diabetol: How is diabetes related to the type of atrial fibrillation?

    Cardiovasc Diabetol: How is diabetes related to the type of atrial fibrillation?

    • Last Update: 2022-01-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Atrial fibrillation (AF) is a common arrhythmia , divided into paroxysmal and non-paroxysmal
    .
    Non-paroxysmal atrial fibrillation is associated with an increased risk of complications


    .


    Atrial fibrillation (AF) is a common arrhythmia , divided into paroxysmal and non-paroxysmal


    The research team searched a total of 5 databases for observational studies on the possibility of diabetes and human atrial fibrillation (compared to other types)


    .


    The research team searched a total of 5 databases for observational studies on the possibility of diabetes and human atrial fibrillation (compared to other types)


    Of the confirmed 1997 articles, 20 were included in the systematic review


    Cross-sectional correlation between diabetes and non-paroxysmal atrial fibrillation (and paroxysmal atrial fibrillation)


    .


    Cross-sectional correlation between diabetes and non-paroxysmal atrial fibrillation (and paroxysmal atrial fibrillation)


    In a meta-analysis of cross-sectional studies, patients with atrial fibrillation and diabetes are 1.


    Longitudinal association between diabetes and non-paroxysmal AF (and paroxysmal AF)


    .


    Longitudinal association between diabetes and non-paroxysmal AF (and paroxysmal AF)


    The overall research results show that diabetes is closely related to non-paroxysmal atrial fibrillation, rather than paroxysmal atrial fibrillation


     References: Alijla, F.
    , Buttia, C.
    , Reichlin, T.
    et al.
    Association of diabetes with atrial fibrillation types: a systematic review and meta-analysis.
    Cardiovasc Diabetol 20, 230 (2021).
    https://doi .
    org/10.
    1186/s12933-021-01423-2 https://doi.
    org/10.
    1186/s12933-021-01423-2 Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.